Category: News
Peadar Noone, MD Introduces the UNC Center for Bronchiectasis Care in New Podcast
The UNC Center for Bronchiectasis Care recently opened in Meadowmont in Chapel Hill, NC. In this new Chair’s Corner podcast, Dr. Ron Falk interviews Dr. Peadar Noone, who is a Professor of Medicine in the Division of Pulmonary & Critical Care Medicine, and Medical Director for this new center. Dr. Noone answers some questions patients commonly ask about bronchiectasis and myc … Read more
Karen Mohlke, PhD and Victor Garcia-Martinez, PhD named Smithies Investigators
The UNC School of Medicine selected Karen Mohlke, PhD, professor of genetics, and Victor Garcia-Martinez, PhD, professor of medicine and member of the UNC Institute for Global Health and Infectious Diseases, as Smithies Investigators, an annual award to honor senior faculty members who have made significant research contributions and achieved international recognition for their w … Read more
Shannon Carson, MD publishes study in JAMA on communication intervention for medical decision-makers
Dr. Carson, Professor of Medicine and Division Chief of Pulmonary Diseases and Critical Care Medicine, along with co-principal investigator Judith Nelson, MD, JD, at Memorial Sloan Kettering Cancer Center, and Christopher Cox, MD, of Duke University, led a four-year, first-of-its kind clinical study.
UNC researchers help create key diagnostic measures for gastrointestinal disorders
UNC School of Medicine faculty members Miranda van Tilburg, PhD and William Whitehead, PhD took on critical roles in amending diagnostic criteria questionnaires for the Rome Foundation, an international nonprofit aimed at improving the lives of the millions of people suffering from functional GI disorders (FGIDs).
UNC researchers help create key diagnostic measures for gastrointestinal disorders
UNC School of Medicine faculty members took on critical roles in amending diagnostic criteria questionnaires for functional GI disorders, which affect millions of people worldwide.
UNC a lead site in clinical trial of three hepatitis C medications
Dr. Michael Fried, director of the UNC Liver Center, is a co-principal investigator of the PRIORITIZE Study.
Darren DeWalt, MD, MPH returns to helm the Division of General Medicine
The Department of Medicine welcomes the return of Dr. Darren DeWalt as Chief of the Division of General Medicine & Clinical Epidemiology. Dr. DeWalt spent many years at UNC during his residency and fellowship training, and then as a faculty member of the Division. He spent the last two years directing the Learning and Diffusion Group at the Centers for Medicare and Medicaid S … Read more
UNC Liver Center partners with Halifax County physicians to improve hepatitis C care
Web-based physician mentoring yields an impressive rate of cure for those treated in their community
UNC Hospitals honored with Mission: Lifeline achievement award
UNC Hospitals earned the award by meeting specific criteria and standards of performance for the quick and appropriate treatment of STEMI patients by providing emergency procedures to re-establish blood flow to blocked arteries when needed.
Dr. Swathi Eluri discusses transition readiness for pediatric EOE patients and their families
Dr. Swathi Eluri Dr. Swathi Eluri presented new findings this year at Digestive Disease Week discussing patient readiness for transition from pediatric to adult care. Read more at Healio: http://www.healio.com/gastroenterology/esophagus/news/online/%7B21afaf8a-7706-4655-b2a8-d2f74e29d6e5%7D/health-care-transition-readiness-lags-in-pediatric-eoe-ege
Next-generation HCV treatments should benefit challenging patient groups
Dr. Michael Fried discusses exciting findings about challenging HCV patient groups with the Digestive Disease Week blog located here: http://ddwblog.org/2016/05/next-generation-hcv-treatments-should-benefit-challenging-patient-groups/
Diabetes drug lowers risk of cardiovascular complications, kidney disease
For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug – liraglutide – a much-needed outcome for people with type 2 diabetes.